Table 1.
Characteristic | N | UPSIT Score | Univariate P-value |
---|---|---|---|
Mean ± SD | |||
All | 127 | 35 ± 3 | NA |
Clinical Diagnosis | 0.55 | ||
USH2 | 80 | 35 ± 3 | |
ARRP | 47 | 34 ± 4 | |
Age at Enrollment (yrs) | 0.90† | ||
<30 | 30 | 34 ± 4 | |
30–39 | 34 | 34 ± 3 | |
40–49 | 37 | 35 ± 3 | |
50–59 | 11 | 34 ± 5 | |
≥60 | 15 | 35 ± 3 | |
Gender | 0.34 | ||
Female | 68 | 35 ± 4 | |
Male | 59 | 34 ± 3 | |
Race/Ethnicity | 0.63 | ||
Non-Hispanic White | 113 | 34 ± 3 | |
Other | 14 | 35 ± 3 | |
Duration of Disease (yrs) ‡ | 0.38† | ||
<10 | 37 | 34 ± 4 | |
10–19 | 46 | 34 ± 4 | |
≥20 | 43 | 35 ± 3 | |
Daily Smoker Ever | 0.23 | ||
Yes | 33 | 34 ± 3 | |
No | 94 | 35 ± 3 | |
Country | 0.02§ | ||
Canada | 4 | 38 ± 1 | |
France | 13 | 34 ± 5 | |
Germany | 11 | 36 ± 2 | |
Netherlands | 10 | 32 ± 3 | |
UK | 10 | 33 ± 3 | |
US | 79 | 35 ± 3 |
Variable was analyzed as continuous.
One participant was missing age of onset (a participant-reported field based on their awareness of visual symptoms) and duration of disease (computed based on age of onset and date of enrollment)
Four participants from Canada were excluded from analysis due to small sample size.